Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK ...

Epstein–Barr virus infects most adults. Understanding its role in Multiple Sclerosis could transform prevention and treatment ...

NESS ZIONA, Israel, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting ...

A new study reveals how Epstein-Barr virus may provoke immune cells to attack the brain, offering fresh hope for treating multiple sclerosis.

In January 2022, a study of 10 million people over 20 years revealed that Epstein-Barr virus increases the risk of multiple ...

A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.

Could plastic byproducts and forever chemicals found in drinking water cause your body to attack your own nervous system? New research from Sweden links higher levels of per- and polyfluoroalkyl ...

People with MS who engage in more physical activity tend to have less severe physical and cognitive disability, a study demonstrated.

New research shows early Multiple Sclerosis brain damage is dynamic and reversible. Myelin swellings can shrink and disappear ...

Multiple sclerosis is a central nervous system autoimmune condition that damages myelin sheath that protects the nervous system, affects brain and spinal cord and leads to aggravated conditions like ...

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million ...